The program offers participants access to Mayo Clinic’s expert mentor network, cutting-edge technologies, and millions of de-identified, longitudinal clinical records.
Mayo Clinic Platform_Accelerate has unveiled its newest cohort of 11 health tech startups set to participate in a comprehensive 30-week program focused on developing and validating AI-driven healthcare solutions.
Participants will gain access to Mayo Clinic’s network of expert mentors, cutting-edge technologies, and millions of de-identified, longitudinal clinical records.
The selected startups, representing both national and international companies, will also have opportunities to connect with leading investors and healthcare executives to help grow their businesses.
“The only way to transform healthcare is by uniting clinical experts with technology innovators,” said John Halamka, M.D., Diercks president of Mayo Clinic Platform. “Our Accelerate program links startups with Mayo Clinic physicians and scientists to turn innovative ideas into practical healthcare solutions.”
The latest cohort features:
- Bowhead Health – developing a radiogenomics platform that uses imaging to predict genomic mutations and guide personalized treatment and clinical trial matching.
- Cleancard – creating an AI-powered, at-home cancer detection test that delivers lab-grade diagnostics in 30 minutes.
- Dart Health – implementing hospital-wide AI solutions by embedding engineering teams on-site to tackle clinical and operational challenges.
- Kanjo Health – utilizing AI and evidence-based insights to provide early, personalized care for children with ADHD and autism.
- Koroid – forecasting clinical demand and automating healthcare logistics to ensure efficient, safe, and quality-driven care.
- MedLink Global – advancing AI-driven precision psychiatry with tools for accurate diagnoses and personalized treatment.
- MyAtlas Health – leveraging AI and wearable data to predict mental health crises early and deliver preventive support.
- Ordinatrum Health – improving critical care through AI-powered, FDA-cleared virtual ICUs and integrated data systems.
- Promed AI – combining at-home testing with multimodal AI to provide affordable, personalized preventive healthcare.
- RTHM – enhancing diagnosis and treatment of complex chronic illnesses such as long COVID and chronic fatigue syndrome.
- Radical – creating a general-purpose AI model for oncology that generates personalized treatment recommendations to improve outcomes and reduce costs.
“We’re excited to welcome our October cohort of 11 companies who are advancing the frontiers of AI in healthcare,” said Jamie Sundsbak, director of the Accelerate program. “Their passion and vision embody the core of Accelerate: bold innovation, strong collaboration, and an unwavering commitment to improving patient outcomes. We’re proud to support their journey and eager to see the breakthroughs they’ll achieve.”
